Yujin Wang
About Yujin Wang
Yujin Wang is a Senior Director of DMPK/Bioanalysis at Day One Biopharmaceuticals, with extensive experience in the pharmaceutical industry, including previous roles at Gilead Sciences and Terns Pharmaceuticals. Wang holds a B.S. in Analytical Chemistry and multiple advanced degrees in related fields.
Work at Day One Biopharmaceuticals
Yujin Wang currently serves as the Senior Director of DMPK/Bioanalysis at Day One Biopharmaceuticals, a position he has held since 2023. His role involves overseeing drug metabolism and pharmacokinetics (DMPK) and bioanalytical strategies to support drug development. Prior to this, he worked as Director of DMPK at the same company from 2022 to 2023. His contributions are focused on advancing the company’s pipeline and ensuring the successful progression of therapeutic candidates.
Education and Expertise
Yujin Wang has a strong educational background in the field of chemistry and biochemistry. He earned a Bachelor of Science degree in Analytical Chemistry from Northwest University. He furthered his studies at the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, where he obtained a Master of Science degree in Separation Science. Additionally, he completed a Master of Science in Biochemistry at the University of Mississippi. His educational foundation supports his expertise in drug metabolism and pharmacokinetics.
Background in Pharmaceutical Industry
Yujin Wang has extensive experience in the pharmaceutical industry, spanning over two decades. He began his career at Pharmacyclics as a Research Associate from 2000 to 2001. He then joined Gilead Sciences, where he worked for 17 years as an Associate Scientist II until 2018. After Gilead, he held positions at Terns Pharmaceuticals as both a Research Scientist and Associate Director, and at Brii Biosciences as Associate Director from 2020 to 2022. His career reflects a progressive advancement in roles and responsibilities within the industry.
Professional Experience at Gilead Sciences
At Gilead Sciences, Yujin Wang worked as an Associate Scientist II for 17 years, from 2001 to 2018. His tenure at Gilead involved significant contributions to drug development processes, particularly in the areas of DMPK and bioanalysis. His experience at Gilead provided him with a solid foundation in the pharmaceutical sector, which he has built upon in subsequent roles at other organizations.